Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry

Inhaled Corticosteroids (ICS) are commonly prescribed to patients with severe COPD and recurrent exacerbations. It is not known what impact ICS cause in terms of COVID-19 positivity or disease severity in COPD. This study examined 27,810 patients with COPD from the Cleveland Clinic COVID-19 registry...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Payal, Majumdar, Uddalak, Zein, Joe, Hatipoğlu, Umur, Attaway, Amy H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174679/
https://www.ncbi.nlm.nih.gov/pubmed/34081722
http://dx.doi.org/10.1371/journal.pone.0252576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174679/
https://www.ncbi.nlm.nih.gov/pubmed/34081722
http://dx.doi.org/10.1371/journal.pone.0252576

Ejemplares similares